EE05293B1 - RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine - Google Patents

RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine

Info

Publication number
EE05293B1
EE05293B1 EEP200200323A EEP200200323A EE05293B1 EE 05293 B1 EE05293 B1 EE 05293B1 EE P200200323 A EEP200200323 A EE P200200323A EE P200200323 A EEP200200323 A EE P200200323A EE 05293 B1 EE05293 B1 EE 05293B1
Authority
EE
Estonia
Prior art keywords
polypeptides
immunoconjugate
binding antibody
peptide binding
pol peptide
Prior art date
Application number
EEP200200323A
Other languages
English (en)
Estonian (et)
Inventor
Harkins Richard
Parkes Deborah
Parry Gordon
W. Schneider Douglas
Steinbrecher Renate
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200323A publication Critical patent/EE200200323A/xx
Publication of EE05293B1 publication Critical patent/EE05293B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
EEP200200323A 1999-12-16 2000-12-15 RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine EE05293B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
PCT/US2000/033901 WO2001044291A2 (en) 1999-12-16 2000-12-15 Polynucleotid encoding the rg1 polypeptide

Publications (2)

Publication Number Publication Date
EE200200323A EE200200323A (et) 2003-10-15
EE05293B1 true EE05293B1 (et) 2010-04-15

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200323A EE05293B1 (et) 1999-12-16 2000-12-15 RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine

Country Status (32)

Country Link
US (5) US6682902B2 (de)
EP (2) EP1237915B1 (de)
JP (1) JP4979867B2 (de)
KR (1) KR100752434B1 (de)
CN (1) CN1297566C (de)
AT (1) ATE440862T1 (de)
AU (1) AU784674B2 (de)
BG (1) BG65898B1 (de)
BR (1) BR0017022A (de)
CA (1) CA2394574A1 (de)
CZ (1) CZ299232B6 (de)
DE (1) DE60042836D1 (de)
DK (1) DK1237915T3 (de)
EE (1) EE05293B1 (de)
ES (1) ES2331106T3 (de)
HR (1) HRP20020549B1 (de)
HU (1) HU229001B1 (de)
IL (2) IL150115A0 (de)
LT (1) LT5046B (de)
ME (1) MEP37808A (de)
MX (1) MXPA02005914A (de)
NO (1) NO330924B1 (de)
NZ (1) NZ519598A (de)
PL (1) PL207634B1 (de)
PT (1) PT1237915E (de)
RO (1) RO122543B1 (de)
RS (1) RS50831B (de)
RU (1) RU2283130C2 (de)
SI (2) SI21140A (de)
SK (2) SK286384B6 (de)
WO (1) WO2001044291A2 (de)
ZA (1) ZA200205638B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1251139A3 (de) * 1998-04-08 2002-12-18 Genentech, Inc. Menschliches mindin-ähliches Protein und dafür kodierende Nukleinsäure
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
NZ544911A (en) * 2003-07-22 2008-12-24 Schering Ag RG1 antibodies and uses thereof
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI610939B (zh) * 2007-02-21 2018-01-11 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
AU2008331507A1 (en) * 2007-11-30 2009-06-11 Bristol-Myers Squibb Company Conjugates of anti-RG-1 antibodies
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
CA2135499A1 (en) 1992-05-14 1993-11-25 James D. Thompson Method and reagent for inhibiting cancer development
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6287777B1 (en) 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
US6177244B1 (en) 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
WO1998008381A1 (en) * 1996-08-26 1998-03-05 University Of Washington Therapeutic and diagnostic applications of perlecan domain i splice variants
AU6961398A (en) 1997-04-10 1998-10-30 Zymogenetics Inc. Secreted f-spondin homologs
JP2002516571A (ja) * 1997-05-06 2002-06-04 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｅｎｔｅｒｏｃｏｃｃｕｓ ｆａｅｃａｌｉｓポリヌクレオチドおよびポリペプチド
EP0986400A4 (de) 1997-05-09 2002-10-09 Smithkline Beecham Corp Integrin ligand, menschliches mindin
ES2312205T3 (es) 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
CA2347085A1 (en) * 1998-10-19 2000-04-27 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EE05627B1 (et) * 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Also Published As

Publication number Publication date
US20090214422A1 (en) 2009-08-27
ZA200205638B (en) 2003-10-15
HU229001B1 (en) 2013-07-29
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
HUP0204224A3 (en) 2004-12-28
CA2394574A1 (en) 2001-06-21
WO2001044291A3 (en) 2002-01-17
PL356220A1 (en) 2004-06-28
SK8482002A3 (en) 2003-02-04
ES2331106T3 (es) 2009-12-22
HRP20020549A2 (en) 2004-04-30
NZ519598A (en) 2004-03-26
CN1297566C (zh) 2007-01-31
JP2003521244A (ja) 2003-07-15
SK286384B6 (sk) 2008-08-05
EP1237915A2 (de) 2002-09-11
NO20022836D0 (no) 2002-06-14
JP4979867B2 (ja) 2012-07-18
LT2002070A (en) 2003-04-25
KR20020065575A (ko) 2002-08-13
ATE440862T1 (de) 2009-09-15
SK288147B6 (sk) 2013-12-02
NO20022836L (no) 2002-08-15
US7307154B2 (en) 2007-12-11
DK1237915T3 (da) 2009-11-16
EE200200323A (et) 2003-10-15
BR0017022A (pt) 2002-11-05
US20020004047A1 (en) 2002-01-10
SI1237915T1 (sl) 2009-12-31
PL207634B1 (pl) 2011-01-31
HRP20020549B1 (hr) 2013-09-30
CZ299232B6 (cs) 2008-05-21
YU44602A (sh) 2005-06-10
AU3074601A (en) 2001-06-25
AU784674B2 (en) 2006-05-25
HUP0204224A2 (hu) 2003-03-28
KR100752434B1 (ko) 2007-08-27
EP2048157B1 (de) 2012-10-10
SI21140A (sl) 2003-08-31
MEP37808A (en) 2011-05-10
US20040152139A1 (en) 2004-08-05
DE60042836D1 (de) 2009-10-08
NO330924B1 (no) 2011-08-22
US7887804B2 (en) 2011-02-15
US20040023307A1 (en) 2004-02-05
BG106823A (bg) 2003-04-30
IL150115A (en) 2013-11-28
CN1434832A (zh) 2003-08-06
RO122543B1 (ro) 2009-08-28
EP1237915B1 (de) 2009-08-26
US20090292112A1 (en) 2009-11-26
US7893217B2 (en) 2011-02-22
BG65898B1 (bg) 2010-04-30
LT5046B (lt) 2003-08-25
RU2283130C2 (ru) 2006-09-10
EP2048157A1 (de) 2009-04-15
MXPA02005914A (es) 2003-02-27
RU2002119208A (ru) 2004-02-27
US6682902B2 (en) 2004-01-27
WO2001044291A2 (en) 2001-06-21
IL150115A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
EE05212B1 (et) Polpeptiidi kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on m?eldud kasvajaraku raviks, mis ekspresseerib APRIL-i
EE05293B1 (et) RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine
NO20005296D0 (no) CD19xCD3-spesifikke polypeptider og anvendelser derav
DE69630710D1 (de) Humaner tumornekrosefaktor delta und epsilon
HK1126668A1 (en) Survivin-derived peptides and use thereof
ATE356149T1 (de) Bispezifische antikörper gegen cd19 und cd16 und deren verwendung
WO2004069876A3 (en) Trimeric polypeptide construct to induce an enduring t cell response
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
DE69434384D1 (de) Metalkomplexbildner
HUP0500637A2 (hu) Neublasztin polimer konjugátumai és alkalmazási eljárásai
NO20014537L (no) AKT-nukleinsyrer, -polypeptider og anvendelse av disse
DE60118359D1 (de) Humanische pellino-polypeptide
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
HUP0302566A2 (hu) Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására
HUP0303430A2 (hu) Csökkentett immunogenitású, módosított protamin
DK1354054T3 (da) Polypeptider der kan binde til CD64, og som omfatter en eller flere heterologe T-celle-epitoper, samt anvendelser deraf
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
WO2004020591A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003014293A3 (en) Novel polypeptide analogs and fusions and their methods of use
WO2004038003A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
WO2001042472A3 (en) DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE
WO2004039952A8 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20141215